Autres langues Agenus Inc.

Actions

AGEN

US00847G8042

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
12,52 ^USD	-5,58 %		+50,84 %	-24,39 %

12/04	Mise à jour sectorielle : Les actions du secteur de la santé en baisse en fin d'après-midi	MT
12/04	Mise à jour sectorielle : Soins de santé	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement	01/05
Agenus Inc. - Botensilimab, Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting	25/04
Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting	24/04
Agenus to Provide First Quarter 2024 Financial Report and Corporate Update	23/04
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer	15/04
Sector Update: Health Care Stocks Slipping Late Afternoon	12/04
Sector Update: Health Care	12/04
Agenus Shares Decline After Update on Early Stage Colorectal Cancer Drug Trial	12/04
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer	12/04
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer	12/04
Agenus Stockholders Approve 1-for-20 Reverse Stock Split	05/04
Agenus Announces Reverse Stock Split of Common Stock	05/04
Agenus : Submission of Matters to a Vote of Security Holders - Form 8-K	05/04
Earnings Flash (AGEN) AGENUS Posts Q4 Revenue $83.8M	14/03
Agenus: Q4 Earnings Snapshot	14/03
Agenus Reports Fourth Quarter and Full Year 2023 Results	14/03
Agenus Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Agenus Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	14/03
Agenus Announces Preclinical Data on BMS-986442 at AACR 2024	07/03
Agenus Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	06/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Agenus Inc.

Actions

AGEN

US00847G8042

Autres langues

Filtres